Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT05767385

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05767385
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05767385. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-17 (actual); primary completion 2025-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Condition
Congenital Heart Disease in Children
Condition
Hypoxia
Condition
Neurodevelopmental Disorders
Condition
Complex Congenital Heart Disease
Intervention (Procedure)
Single Arm
Intervention (Procedure)
Neonatal Neurobehavioral Scale
Lead sponsor
University of Utah (class: other)
Collaborator
Primary Children's Hospital (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05767385
Content hash
11718ac8e41eb9a370ef330ed1f0cb6c5ac19b78c83b8a853af730b16fba2412